Annual Total Long Term Liabilities
N/A
December 1, 2024
Summary
- BSX annual total long term liabilities is not available.
Performance
BSX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$11.21 B
+$289.00 M+2.65%
September 30, 2024
Summary
- As of February 7, 2025, BSX quarterly total long term liabilities is $11.21 billion, with the most recent change of +$289.00 million (+2.65%) on September 30, 2024.
- Over the past year, BSX quarterly long term liabilities has increased by +$539.00 million (+5.05%).
- BSX quarterly long term liabilities is now -17.27% below its all-time high of $13.55 billion, reached on June 30, 2006.
Performance
BSX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BSX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +5.0% |
| 3 y3 years | - | -1.1% |
| 5 y5 years | - | -1.1% |
BSX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.2% | +8.5% | ||
| 5 y | 5-year | -9.1% | +8.5% | ||
| alltime | all time | -17.3% | >+9999.0% |
Boston Scientific Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.21 B(+2.6%) |
| Jun 2024 | - | $10.92 B(-5.7%) |
| Mar 2024 | - | $11.59 B(+8.5%) |
| Dec 2023 | $10.67 B(-3.8%) | $10.67 B(+3.3%) |
| Sep 2023 | - | $10.34 B(-2.1%) |
| Jun 2023 | - | $10.55 B(-1.4%) |
| Mar 2023 | - | $10.70 B(-3.5%) |
| Dec 2022 | $11.09 B(-2.1%) | $11.09 B(+3.1%) |
| Sep 2022 | - | $10.76 B(-2.7%) |
| Jun 2022 | - | $11.05 B(-2.4%) |
| Mar 2022 | - | $11.33 B(-0.1%) |
| Dec 2021 | $11.33 B(-3.7%) | $11.33 B(-0.5%) |
| Sep 2021 | - | $11.39 B(+2.2%) |
| Jun 2021 | - | $11.15 B(-5.4%) |
| Mar 2021 | - | $11.79 B(+0.2%) |
| Dec 2020 | $11.77 B(-0.4%) | $11.77 B(-1.7%) |
| Sep 2020 | - | $11.98 B(-1.0%) |
| Jun 2020 | - | $12.10 B(-1.9%) |
| Mar 2020 | - | $12.33 B(+4.3%) |
| Dec 2019 | $11.82 B(+68.6%) | $11.82 B(-7.7%) |
| Sep 2019 | - | $12.80 B(+27.6%) |
| Jun 2019 | - | $10.03 B(-0.6%) |
| Mar 2019 | - | $10.09 B(+43.9%) |
| Dec 2018 | $7.01 B(+10.0%) | $7.01 B(+0.1%) |
| Sep 2018 | - | $7.01 B(-1.5%) |
| Jun 2018 | - | $7.12 B(-0.9%) |
| Mar 2018 | - | $7.18 B(+12.7%) |
| Dec 2017 | $6.38 B(-18.0%) | $6.38 B(+2.5%) |
| Sep 2017 | - | $6.22 B(-9.2%) |
| Jun 2017 | - | $6.85 B(-7.5%) |
| Mar 2017 | - | $7.40 B(-4.8%) |
| Dec 2016 | $7.78 B(-17.1%) | $7.78 B(-5.2%) |
| Sep 2016 | - | $8.20 B(-2.8%) |
| Jun 2016 | - | $8.44 B(-2.5%) |
| Mar 2016 | - | $8.65 B(-7.8%) |
| Dec 2015 | $9.38 B(+21.5%) | $9.38 B(-1.9%) |
| Sep 2015 | - | $9.57 B(+11.2%) |
| Jun 2015 | - | $8.61 B(+14.6%) |
| Mar 2015 | - | $7.51 B(-2.8%) |
| Dec 2014 | $7.72 B(-5.9%) | $7.72 B(-5.8%) |
| Sep 2014 | - | $8.20 B(+0.5%) |
| Jun 2014 | - | $8.16 B(+1.0%) |
| Mar 2014 | - | $8.08 B(-1.5%) |
| Dec 2013 | $8.21 B(-3.6%) | $8.21 B(-2.9%) |
| Sep 2013 | - | $8.45 B(+6.8%) |
| Jun 2013 | - | $7.92 B(-8.2%) |
| Mar 2013 | - | $8.62 B(+1.3%) |
| Dec 2012 | $8.51 B(+4.7%) | $8.51 B(+3.1%) |
| Sep 2012 | - | $8.26 B(-0.5%) |
| Jun 2012 | - | $8.30 B(+2.2%) |
| Mar 2012 | - | $8.12 B(-0.1%) |
| Dec 2011 | $8.13 B(-1.1%) | $8.13 B(+0.4%) |
| Sep 2011 | - | $8.09 B(-0.4%) |
| Jun 2011 | - | $8.13 B(-6.2%) |
| Mar 2011 | - | $8.66 B(+5.3%) |
| Dec 2010 | $8.22 B(-16.6%) | $8.22 B(-2.1%) |
| Jun 2010 | - | $8.40 B(-8.3%) |
| Mar 2010 | - | $9.16 B(-7.1%) |
| Dec 2009 | $9.85 B(-8.2%) | $9.85 B(+1.0%) |
| Sep 2009 | - | $9.76 B(-2.7%) |
| Jun 2009 | - | $10.03 B(-3.5%) |
| Mar 2009 | - | $10.40 B(-3.1%) |
| Dec 2008 | $10.73 B | $10.73 B(+1.3%) |
| Sep 2008 | - | $10.60 B(-5.6%) |
| Jun 2008 | - | $11.23 B(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $11.56 B(-10.0%) |
| Dec 2007 | $12.85 B(-2.1%) | $12.85 B(+3.3%) |
| Sep 2007 | - | $12.44 B(-0.4%) |
| Jun 2007 | - | $12.49 B(-5.0%) |
| Mar 2007 | - | $13.15 B(+0.2%) |
| Dec 2006 | $13.13 B(+439.1%) | $13.13 B(-1.2%) |
| Sep 2006 | - | $13.29 B(-2.0%) |
| Jun 2006 | - | $13.55 B(+464.0%) |
| Mar 2006 | - | $2.40 B(-1.3%) |
| Dec 2005 | $2.44 B(+58.1%) | $2.44 B(-19.7%) |
| Sep 2005 | - | $3.03 B(+43.7%) |
| Jun 2005 | - | $2.11 B(+28.3%) |
| Mar 2005 | - | $1.65 B(+6.8%) |
| Dec 2004 | $1.54 B(+6.6%) | $1.54 B(-26.9%) |
| Sep 2004 | - | $2.11 B(-1.6%) |
| Jun 2004 | - | $2.14 B(+142.9%) |
| Mar 2004 | - | $882.00 M(-38.9%) |
| Dec 2003 | $1.44 B(+36.2%) | $1.44 B(+21.5%) |
| Sep 2003 | - | $1.19 B(+2.2%) |
| Jun 2003 | - | $1.16 B(+11.2%) |
| Mar 2003 | - | $1.04 B(-1.4%) |
| Dec 2002 | $1.06 B(-6.0%) | $1.06 B(+11.9%) |
| Sep 2002 | - | $947.00 M(-1.5%) |
| Jun 2002 | - | $961.00 M(-6.2%) |
| Mar 2002 | - | $1.02 B(-9.2%) |
| Dec 2001 | $1.13 B(+67.6%) | $1.13 B(+17.6%) |
| Sep 2001 | - | $959.00 M(+44.4%) |
| Jun 2001 | - | $664.00 M(-0.2%) |
| Mar 2001 | - | $665.00 M(-1.2%) |
| Dec 2000 | $673.00 M(-15.1%) | $673.00 M(-0.4%) |
| Sep 2000 | - | $676.00 M(-1.0%) |
| Jun 2000 | - | $683.00 M(-1.0%) |
| Mar 2000 | - | $690.00 M(-13.0%) |
| Dec 1999 | $793.00 M(-45.4%) | $793.00 M(-6.0%) |
| Sep 1999 | - | $844.00 M(-26.2%) |
| Jun 1999 | - | $1.14 B(-15.2%) |
| Mar 1999 | - | $1.35 B(-7.2%) |
| Dec 1998 | $1.45 B(+734.5%) | $1.45 B(+129.9%) |
| Sep 1998 | - | $631.60 M(-7.3%) |
| Jun 1998 | - | $681.70 M(-0.2%) |
| Mar 1998 | - | $683.10 M(+292.6%) |
| Dec 1997 | $174.00 M(+61.0%) | $174.00 M(+3.3%) |
| Sep 1997 | - | $168.40 M(+41.5%) |
| Jun 1997 | - | $119.00 M(-9.8%) |
| Mar 1997 | - | $132.00 M(+22.1%) |
| Dec 1996 | $108.10 M(+106.7%) | $108.10 M(+223.7%) |
| Sep 1996 | - | $33.40 M(-20.1%) |
| Jun 1996 | - | $41.80 M(+25.5%) |
| Mar 1996 | - | $33.30 M(-36.3%) |
| Dec 1995 | $52.30 M(+190.6%) | $52.30 M(+5.0%) |
| Sep 1995 | - | $49.80 M(-2.5%) |
| Jun 1995 | - | $51.10 M(-2.5%) |
| Mar 1995 | - | $52.40 M(+191.1%) |
| Dec 1994 | $18.00 M(-7.2%) | $18.00 M(+1.1%) |
| Sep 1994 | - | $17.80 M(-20.5%) |
| Jun 1994 | - | $22.40 M(+45.5%) |
| Mar 1994 | - | $15.40 M(-20.6%) |
| Dec 1993 | $19.40 M(+162.2%) | $19.40 M(-21.8%) |
| Sep 1993 | - | $24.80 M(+12.7%) |
| Jun 1993 | - | $22.00 M(+189.5%) |
| Mar 1993 | - | $7.60 M(+2.7%) |
| Dec 1992 | $7.40 M(-65.4%) | $7.40 M(+15.6%) |
| Sep 1992 | - | $6.40 M(-72.6%) |
| Jun 1992 | - | $23.40 M(+0.9%) |
| Mar 1992 | - | $23.20 M(+8.4%) |
| Dec 1991 | $21.40 M | $21.40 M |
FAQ
- What is the all time high annual total long term liabilities for Boston Scientific?
- What is Boston Scientific quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Boston Scientific?
- What is Boston Scientific quarterly long term liabilities year-on-year change?
What is the all time high annual total long term liabilities for Boston Scientific?
Boston Scientific all-time high annual total long term liabilities is $13.13 B
What is Boston Scientific quarterly total long term liabilities?
The current quarterly long term liabilities of BSX is $11.21 B
What is the all time high quarterly long term liabilities for Boston Scientific?
Boston Scientific all-time high quarterly total long term liabilities is $13.55 B
What is Boston Scientific quarterly long term liabilities year-on-year change?
Over the past year, BSX quarterly total long term liabilities has changed by +$539.00 M (+5.05%)